Digital cardiac health company Eko Health announced that clinicians in the UK can now purchase the company's CORE 500 Digital Stethoscope, Eko+ membership and accessories via Eko's website and Amazon ...

This expansion builds on Eko's international momentum and collaborations with UK institutions, including Imperial College London, where Eko's technology supports earlier detection of heart disease in ...

Landmark TRICORDER study finds major gains in detection of heart failure, atrial fibrillation, and valvular disease with Eko Health's AI-enabled stethoscopes in routine exams. SAN FRANCISCO, Sept. 11, ...

For the past decade, Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, particularly heart and lung conditions, during routine ...

The CORE 500™ Digital Stethoscope is Eko's most advanced stethoscope to date, designed to enhance clinical assessments through patented audio technology with three listening modes (cardiac, pulmonary, ...

Cardiovascular and pulmonary diseases are among the leading causes of death worldwide, with millions of patients unaware of their risk factors, often due to limited access to effective detection tools ...

PHILADELPHIA, Nov. 25, 2025 /PRNewswire/ -- Impilo, a leading provider in enabling at-home healthcare through software, logistics, and operations support, announced a strategic partnership between its ...

Berkeley, California-based Eko Devices has received FDA 510(k) clearance for its smartphone-enabled stethoscope, called Eko Core as well as the companion smartphone app. Eko Devices, which describes ...

AI has begun to play an important role in aiding physicians in diagnoses — and the Centers for Medicare & Medicaid Services has recognized this progress in recent years by granting dedicated ...

SAN FRANCISCO, Sept. 11, 2025 /PRNewswire/ -- Eko Health, a leader in AI-powered cardiac and pulmonary disease detection, today announced groundbreaking results from the TRICORDER (Triple ...